The use of compounds of the formula ##STR00001## and pharmaceutically acceptable salts thereof, alone or in combination for the treatment of transplant rejection, wherein the substituents are further defined in the application.

 
Web www.patentalert.com

< Method for producing a fermented hydrolyzed medium containing microorganisms

< Methanocarba cycloakyl nucleoside analogues

> Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy

> Albumin-free factor VIII formulations

~ 00281